DK

Deepak Kumar

Active Director Director DIN 08570142
DIN 08570142 First appointment Sep 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2019
Shareholding value •••• Premium profile

About Deepak Kumar

Data last updated:

Deepak Kumar is a Director at Cadit Pharma Private Limited (since 2019). The company operates in Chemicals. Cadit Pharma Private Limited reported revenue of ₹3.3 Lakh (FY 2024).

DIN 08570142
Primary Designation Director
Industry Chemicals
First Appointment 23 Sep 2019
Oldest Company Age 7 yrs
Largest company Cadit Pharma Private Limited · ₹3.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cadit Pharma Private Limited U24100BR2019PTC043434
Director23 Sep 20192019₹3.3 Lakh (FY 2024)Active

Board colleagues of Deepak Kumar

NameDINCompanyDesignation
Priyanka Kumari08570193Cadit Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cadit Pharma Private Limited
Premium access

Shareholding and investment profile for Deepak Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepak Kumar

Deepak Kumar currently holds 1 directorship: Cadit Pharma Private Limited (Director, since 23 Sep 2019, revenue ₹3.3 Lakh (FY 2024)).

Deepak Kumar was first appointed on 23 Sep 2019 as Director at Cadit Pharma Private Limited.

The current boards of Deepak Kumar's companies include Priyanka Kumari (Cadit Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available